The application of supersaturated systems to percutaneous drug delivery

Transdermal Drug Delivery, Second Edition: Revised and Expanded

Volumn , Issue , 2002, Pages 305-326

  Pellett, Mark ^a   Raghavan, S Lakshmi ^b   Hadgraft, Jonathan ^b   Davis, Adrian ^c  

^a Wyeth Consumer Hlth Care   (United Kingdom)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84964467271     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (58)

1. A Abd El-Bary, MAA Kassem, NST Foda, SS Badawi. Controlled crystallization of chlorpropamide from surfactant and polymer solutions. Drug Dev Ind Pharm 16:1649-1660, 1990.
2. C Chiang, GL Flynn, ND Weiner, GJ Szpunar. Bioavailability assessment of topical delivery systems: effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations. Int J Pharm 55:229-236, 1989.
3. MF Coldman, BJ Poulsen, T Higuchi. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles. J Pharm Sci 58: 1098-1102, 1969.
4. OI Corrigan, RF Timoney. Anomalous behaviour of some hydroflumethazide crystal samples. J Pharm Pharmacol 26:838-840, 1974.
5. OI Corrigan, RF Timoney. The influence of polyvinylpyrrolidone on the dissolution properties of hydroflumethazide. J Pharm Pharmacol 27:759-764, 1975.
6. AF Davis, J Hadgraft. Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int J Pharm 76, 1-8, 1991a.
7. AF Davis, J Hadgraft. The use of supersaturation in topical drug delivery. In: Prediction of Percutaneous Penetration: Methods, Measurements, Modelling (RC Scott, RH Guy, J Hadgraft, HE Bodde, eds.). London: IBC Technical Services, 1991b, Vol. 2, pp 279-287.
8. AF Davis, J Hadgraft. Supersaturated solutions as topical drug delivery systems. In: Pharmaceutical Skin Penetration Enhancement (KA Walters, J Hadgraft, eds.). New York: Marcel Dekker, 1993, Vol. 59, pp 243-267.
9. AF Davis. Novel formulations for improved topical therapy. Thesis, University of Wales, 1995.
10. JH De Smidt, JG Fokkens, H Grijseels, DJA Crommelin. Dissolution of theophylline monohydrate and anhydrous theophylline in buffer solutions. J Pharm Sci 75:497-501, 1986.
11. MMR Dias, SL Raghavan, MA Pellett, WJ Pugh, J Hadgraft. The effect of β-cyclodextrins on the permeation of diclofenac from supersaturated solutions. Int J Pharm 2002.
12. AR Ebian, MA Moustafa, SA Khalil, MM Motawi. Succinylsulfathiazole crystal forms II: Effects of additives on kinetics of interconversion. J Pharm Sci64:1481-1484, 1975.
13. J-Y Fang, C-T Kuo, Y-B Huang, P-C Wu, Y-H Tsai. Transdermal delivery of sodium nonivamide acetate from volatile vehicles: effects of polymers. Int J Pharm 176:157-167, 1999.
14. MN Femi-Oyewo, MS Spring. Studies on paracetamol crystals produced by growth in aqueous solutions. Int J Pharm 112:17-28, 1994.
15. FC Frank. The influence of dislocations on crystal growth. Discussions of the Faraday Society 5:48-54, 1949.
16. DF Hager, MJ Laubach, JW Sharkey, JR Siverly. In vitro iontophoretic delivery of CQA 206-291: influence of ethanol. J Cont Rel 23:175-182, 1993.
17. A Hasegawa, R Kawamura, H Nakagawa, I Sugimoto. Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents. Chem Pharm Bull 33:3429-3435, 1985.
18. T Henmi, M Fujii, K Kikuchi, M Matsumoto. Application of an oily gel formed by hydrogenated soybean phospholipids as percutaneous-type enhancer. Chem Pharm Bull 42:651-655, 1994.
19. T Higuchi. Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem 11:85-97, 1960.
20. GA Holder, J Thorne. Inhibition of crystallisation by polymers. Polymer Preprints Am Chem Soc Div Poly Chem 20:766-769, 1979.
21. M Iervolino, SL Raghavan, J Hadgraft. Membrane penetration enhancement of ibuprofen using supersaturation. Int J Pharm 198:229-238, 2000.
22. M Iervolino, BM Capello, SL Raghavan, J Hadgraft. Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int J Pharm212:131-141, 2001.
23. J Kemken, A Ziegler, BW Muller. Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Pharm Res 9:554-558, 1992.
24. EV Khamskii. Crystallisation from Solutions. New York: Consultants Bureau, 1969.
25. S Khoshkhoo, J Anwar. Crystallization of polymorphs: effects of supersaturation and solvent. J Pharm Pharmacol 43:36, 1991.
26. S Kondo, I Sugimoto. Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier. J Pharmacobio-Dyn 10:587-594, 1987.
27. S Kondo, H Yamasaki-Konishi, I Sugimoto. Enhancement of transdermal delivery by superfluous thermodynamic potential. II. In vitro-in vivo correlation of percutaneous nifedipine transport. J Pharmacobio-Dyn 10:662-668,1987a.
28. S Kondo, K Yamanaka, I Sugimoto. Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats. J Pharmacobio-Dyn 10:743-749, 1987b.
29. BC Lippold. How to optimize drug penetration through the skin. Pharm Acta Helv 67:294-300, 1992.
30. VHW Mak, RO Potts, RH Guy. Oleic acid concentration and effect in human stratum corneum: non-invasive determination by attenuated total reflectance infrared spectroscopy in vivo. J Cont Rel 12:67-75, 1990.
31. CGT Mathias, RH Guy, RS Hinz, HI Maibach. Percutaneous penetration enhancement of solvent-deposited solids by the volatile solvent. J Invest Derm 84:360, 1985.
32. NA Megrab, AC Williams, BW Barry. Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation. J Cont Rel, 36:277-294, 1995.
33. SC Mehta, PD Bernardo, WI Higuchi, AP Simonelli. Rate of crystal growth of sulfathiazole and methylprednisolone. J Pharm Sci 59:638-644, 1970.
34. K Moser, K Kriwet, C Froehlich, YN Kalia, RH Guy. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharmaceutical Research 18(7):1006-1011, 2001a.
35. K Moser, K Kriwet, C Froehlich, A Naik, YN Kalia, RH Guy. Permeation enhancement of a highly lipophilic drug using supersaturated systems. Journal of Pharmaceutical Sciences 90:607-616, 2001b.
36. K Moser, K Kriwet, YN Kalia, RH Guy. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. Journal of Controlled Release 73: 245-253, 2001c.
37. K Moser, K Kriwet, YN Kalia, RH Guy. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery. International Journal of Pharmaceutics 224:169-176, 2001d.
38. K Moser, K Kriwet, A Naik, YN Kalia, RH Guy. Passive skin penetration enhancement and its quantification in vitro. European Journal of Pharmaceutics and Biopharmaceutics 52:103-112, 2001e.
39. S Miyazaki, M Nakano, T Arita. Effect of additives on the polymorphic transformation of chlortetracycline hydrochloride crystals. Chem Pharm Bull 24: 2094-2101, 1976.
40. JW Mullin. Crystallization, London: Butterworths, 1961, pp 26-29.
41. MA Pellett, S Castellano, J Hadgraft, A Davis. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J Cont Rel 46:205-214, 1997a.
42. MA Pellett, MS Roberts, J Hadgraft. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm 151:91-98, 1997b.
43. MA Pellett, AC Watkinson, KR Brain, J Hadgraft. Synergism between supersaturation and chemical enhancement in the permeation of flurbiprofen through human skin. In: Perspectives in Percutaneous Penetration (KR Brain, VJ James, KA Walters, eds.). Cardiff: STS Publishing, 1998, 173-176.
44. BJ Poulsen, E Young, V Coquilla, M Katz. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester. J Pharm Sci 57:928-933, 1968.
45. SL Raghavan, A Trividic, AF Davis, J Hadgraft. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm 193:231-237, 2000.
46. SL Raghavan, B Kiepfer, AF Davis, SG Kazarian, J Hadgraft. Membrane transport of hydrocortisone acetate from supersaturated solutions: influence of polymers. Int J Pharm 221:95-105, 2001a.
47. SL Raghavan, A Trividic, AF Davis, J Hadgraft. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 212:213-221, 2001b.
48. N Rodriguez-Hornedo, W Hsui-Jean. Crystal growth kinetics of theophylline monohydrate. Pharm Res 8:643-648, 1991.
49. FP Schwarb, G Imanidis, EW Smith, JM Haigh, C Surber. Effect of concentration and degree of saturation of topical fluocinonide formulations and in vitro membrane transport and in vivo availability on human skin. Pharm Res 16: 909-915, 1999.
50. H Sekikawa, M Nakano, T Arita. Inhibitory effect of polyvinylpyrrolidone on the crystallization of drugs. Chem Pharm Bull 26:118-126, 1978.
51. AP Simonelli, SC Mehta, WI Higuchi. Inhibition of sulfathiazole crystal growth. J Pharm Sci 59:633-638, 1970.
52. E Shefter, T Higuchi. Dissolution behaviour of crystalline solvated and nonsolvated forms of some pharmaceuticals. J Pharm Sci 52:781-791, 1963.
53. S Tanaka, Y Takashima, H Murayama, S Tsuchiya. Studies on drug release from ointments. V. Release of hydrocortisone butyrate propionate from topical dosage forms to silicone rubber. Int J Pharm 27:29-38, 1985.
54. F Theeuwes, RM Gale, RW Baker. Transference: a comprehensive parameter governing permeation of solutes through membranes. J Mem Sci 1:3-16, 1976.
55. JJ Torres-Labandeira, P Davignon, J Pitha. Oversaturated solutions of drug in hydroxypropylcyclodextrins: parenteral preparation of pancratistatin. J Pharm Sci 80:384-386, 1990.
56. JN Twist, JL Zatz. Influence of solvents on paraben permeation through idealized skin model membranes. J Soc Cosmet Chem 37:429-444, 1986.
57. K Uekama, K Oh, T Irie, M Otagiri, Y Nishimiya, T Nara. Stabilization of isosor-bide 5-mononitrate in solid state by B-cyclodextrin complexation. Int J Pharm 25:339–346, 1985.
58. K Uekama, K Ikegami, Z Wang, Y Horiuchi, F Hirayama. Inhibitory effect of 2-hydroxypropyl-B-cyclodextrin on crystal growth of nifedipine during storage: superior dissolution and oral bioavailability compared with polyvinylpyrrolidone k-30. J Pharm Pharmacol 44:73–78, 1992.